LncRNA GClnc1 promotes osteosarcoma progression by stabilizing NONO and blocking FBXW7-mediated ubiquitination
Our study elucidated that lncRNA GClnc1 participates in the progression of OS by regulating the NONO signal pathway. Targeting GClnc1 provides a potential target for future clinical treatment of OS.
Authors
- Quanhui Jiao
- Zhengzai Dai
- Shifan Lin
- Xiaofeng Tang (ORCID: https://orcid.org/0000-0003-4513-0389)
- Chong Guo (ORCID: https://orcid.org/0000-0001-7803-3206)
- Jiongfeng Zhang
- Le Zou
- Zhiping Zhang (ORCID: https://orcid.org/0000-0002-0000-3063)
- Feifei Zhang (ORCID: https://orcid.org/0009-0009-3980-3672)
- Xiaohui Luo (ORCID: https://orcid.org/0000-0001-9801-5099)
- Xiaobin Lv (ORCID: https://orcid.org/0000-0003-3816-1996)
Institutions
- Jiangxi University of Traditional Chinese Medicine (CN)
- Nanchang University (CN)
- Third Affiliated Hospital of Nanchang University (CN)
Publication Details
- Journal
- BMC Cancer
- Published
- 2024-11-11
- DOI
- https://doi.org/10.1186/s12885-024-13138-0
- Citations
- 3
- Primary Topic
- Cancer-related molecular mechanisms research
- Type
- article
- Field-Weighted Citation Impact
- 0.86
Funders
- National Natural Science Foundation of China
- Natural Science Foundation of Jiangxi Province